Task: Answer the MCQ question.
Query: Which drug exhibits a -2.225% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCn1nc(C)c(CN2CCC(n3nccc3NC(=O)CCCc3ccccc3)CC2)c1C
b. O=C(NCc1ccco1)c1cnn2c1NC(c1ccccc1)CC2C(F)(F)F
c. CC(C)CCN1CCN(Cc2cn[nH]c2C2CCCCC2)CC1CCO
Answer: b. O=C(NCc1ccco1)c1cnn2c1NC(c1ccccc1)CC2C(F)(F)F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCc1ccco1)c1cnn2c1NC(c1ccccc1)CC2C(F)(F)F
O=C(NCc1ccco1)c1cnn2c1NC(c1ccccc1)CC2C(F)(F)F
N-(furan-2-ylmethyl)-5-phenyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide